Date: 12 September 2017
Time: 18:00 - 20:00
Venue: Pfizer Lecture Theatre, Department of Chemistry. Lensfield Road, CB2 1EW
Organised by Cambridge Enterprise as part of their Commercialisation Roadshow series, this event will feature Dr. Jason Mellad, CEO at Cambridge Epigenetix. He will give a talk about the company’s route to commercialisation and how the relationship with Cambridge Enterprise supported this journey.
Cambridge Epigenetix, a pioneer in the development of epigenetic sequencing, was founded in 2012 by Prof Shankar Balasubramanian of the Department of Chemistry. The company is focused on developing best-in-class tools to make studying DNA methylation and DNA hydroxymethylation as easy as studying DNA sequencing.
This event will provide a networking opportunity to meet like-minded people with an interest in entrepreneurship and is open to academics, postdocs and PhDs alike from across all departments at the University of Cambridge.
Click here for more information and to book your place.
Date:
Tuesday, 12 September, 2017 - 18:00
